Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) EBT Margin (2021 - 2025)

Historic EBT Margin for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 2.15%.

  • Verrica Pharmaceuticals' EBT Margin rose 12813500.0% to 2.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 78.66%, marking a year-over-year increase of 5869300.0%. This contributed to the annual value of 976.92% for FY2024, which is 3302800.0% up from last year.
  • Latest data reveals that Verrica Pharmaceuticals reported EBT Margin of 2.15% as of Q3 2025, which was up 12813500.0% from 3.09% recorded in Q2 2025.
  • In the past 5 years, Verrica Pharmaceuticals' EBT Margin registered a high of 18.21% during Q3 2022, and its lowest value of 17808.11% during Q1 2023.
  • For the 5-year period, Verrica Pharmaceuticals' EBT Margin averaged around 2983.53%, with its median value being 1044.22% (2023).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -158429100bps in 2023, then soared by 172770100bps in 2024.
  • Quarter analysis of 5 years shows Verrica Pharmaceuticals' EBT Margin stood at 7.8% in 2021, then crashed by -111608bps to 8713.24% in 2022, then surged by 86bps to 1239.89% in 2023, then tumbled by -218bps to 3940.12% in 2024, then skyrocketed by 100bps to 2.15% in 2025.
  • Its last three reported values are 2.15% in Q3 2025, 3.09% for Q2 2025, and 290.67% during Q1 2025.